Progress in Direct Striatal Delivery of l-Dopa via Gene Therapy for Treatment of Parkinson's Disease Using Recombinant Adeno-Associated Viral Vectors

This publication has 145 references indexed in Scilit:

• Gene Therapeutic Strategies for Neuroprotection: Implications for Parkinson's Disease
  Experimental Neurology, 1997
• Immune responses to adenovirus vectors in the nervous system
  Trends in Neurosciences, 1996
• Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.
  Proceedings of the National Academy of Sciences, 1996
• Tetrahydrobiopterin biosynthesis in the rat brain: heterogeneity of GTP cyclohydrolase I mRNA expression in monoamine-containing neurons
  Neurochemistry International, 1996
• Ecdysone-inducible gene expression in mammalian cells and transgenic mice.
  Proceedings of the National Academy of Sciences, 1996
• Dopa‐responsive dystonia: Pathological and biochemical observations in a case
  Annals of Neurology, 1994
• Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce l-dopa
  Neuron, 1991
• Tetrahydrobiopterin-dependent production of l-DOPA in NRK fibroblasts transfected with tyrosine hydroxylase cDNA: future use for intracerebral grafting
  Neuroscience Letters, 1990
• Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease
  New England Journal of Medicine, 1988
• Dopaminergic deficiency is more pronounced in putamen than in nucleus caudatus in Parkinson’s disease
  Neurochemical Pathology, 1983